Alzheimer’s disease remains one of medicine’s toughest challenges, affecting millions and costing trillions of dollars ...

GoodRx reports that in 2025, novel drug and biosimilar approvals lag slightly behind last year, while first generic approvals ...

An epidemic that's been sustained for 44 years might finally be quelled, with the milestone approval of the first HIV drug ...

Insiders tell CNN the FDA’s AI is “hallucinating” studies and can’t access key documents. Agency leaders insist the AI is getting better, and use is not mandatory.

Diclegis is now the only FDA-approved drug for morning sickness. April 9, 2013— -- The U.S. Food and Drug Administration Monday approved Diclegis, a drug used to treat pregnant women for ...

Please provide your email address to receive an email when new articles are posted on . Large-data AI models may also be used to identify non-FDA-approved drugs for Parkinson’s disease. There is ...

Cory Simpson, MD, PhD, assistant professor of dermatology at the University of Washington, spoke to the need for more treatment options in genetic skin conditions and the possibility of drug ...

The approval was in advance of the June 30 Prescription Drug User Fee Act action date. Verastem shares were flat at $6.69 prior to a trading halt for pending news. Write to Josh Beckerman at josh ...

A preclinical study finds that a drug already FDA-approved for treating inflammatory conditions may help ... (2025, April 22). A repurposed anti-inflammatory drug may help treat alcohol use ...

UroGen Pharma shares surged after the company received Food and Drug Administration approval for bladder cancer drug Zusduri, previously known as UGN-102. The stock was recently up 36% to $9.96.

The investment quickly bore fruit: The FDA approved a record-breaking number of generic drugs in 2017 and 2018, yielding an estimated $26 billion in savings for American consumers.. Recently ...